SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000903423-13-000613
Filing Date
2013-11-12
Accepted
2013-11-12 15:11:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 tpggroupaerie-13d_1111.htm SC 13D 80565
  Complete submission text file 0000903423-13-000613.txt   82165
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Subject) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87680 | Film No.: 131209816
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Group Holdings (SBS) Advisors, Inc. (Filed by) CIK: 0001495741 (see all company filings)

IRS No.: 271650453 | State of Incorp.: DE
Type: SC 13D